These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21570361)

  • 21. Prevention of recurrent ischemic stroke.
    Dickerson LM; Carek PJ; Quattlebaum RG
    Am Fam Physician; 2007 Aug; 76(3):382-8. PubMed ID: 17708138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
    Simmons BB; Yeo A; Fung K; ;
    Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention.
    Thomson R; Eccles M; Wood R; Chinn DJ
    Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention.
    Fuentes B; Ortega-Casarrubios MA; Martínez P; Díez-Tejedor E
    Cerebrovasc Dis; 2007; 24 Suppl 1():96-106. PubMed ID: 17971644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic interventions for prevention of recurrent ischemic stroke.
    Kirshner HS
    Am J Manag Care; 2008 Jun; 14(6 Suppl 2):S212-26. PubMed ID: 18611103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary stroke prevention in the era of carotid stenting: update on recent trials.
    Hassoun HT; Malas MB; Freischlag JA
    Arch Surg; 2010 Oct; 145(10):928-35. PubMed ID: 20956760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endarterectomy for preventing stroke in symptomatic and asymptomatic carotid stenosis. Review of clinical trials and recommendations for surgical therapy.
    Levinson MM; Rodriguez DI
    Heart Surg Forum; 1999; 2(2):147-68. PubMed ID: 11276473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary prevention of stroke in Saskatchewan, Canada: hypertension control.
    Bartsch JA; Teare GF; Neufeld A; Hudema N; Muhajarine N
    Int J Stroke; 2013 Oct; 8 Suppl A100():32-8. PubMed ID: 23088414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of cardiovascular events in elderly people.
    Andrawes WF; Bussy C; Belmin J
    Drugs Aging; 2005; 22(10):859-76. PubMed ID: 16245959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient ischaemic attack: clinical relevance, risk prediction and urgency of secondary prevention.
    Giles MF; Rothwell PM
    Curr Opin Neurol; 2009 Feb; 22(1):46-53. PubMed ID: 19155761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What are the patient-held illness beliefs after a transient ischaemic attack, and do they determine secondary prevention activities: an exploratory study in a North London General Practice.
    Kamara S; Singh S
    Prim Health Care Res Dev; 2012 Apr; 13(2):165-74. PubMed ID: 22433271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations.
    Hankey GJ; Warlow CP
    Lancet; 1999 Oct; 354(9188):1457-63. PubMed ID: 10543686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary and secondary prevention of stroke].
    Trenkwalder P; Rüchardt A
    Dtsch Med Wochenschr; 2015 Oct; 140(21):1593-8. PubMed ID: 26488098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.